Physician
Allergy & Immunology
Dr. Peter S. Creticos, MD
Peter S. Creticos practices Allergy & Immunology. He studied medicine at Medical University of South Carolina. He has 3 awards "Fellow (FAAAAI)", "Super Doctor" and "Top MD". Peter S. Creticos, MD is a published doctor. He has 54 publications published. The most current publication "Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study Group."
Publications
- Safety and tolerability of a short ragweed sublingual immunotherapy tablet.
- Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial.
- Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.
- Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
- Legends in allergy: Philip S. Norman and Lawrence M. Lichtenstein--the Hopkins experience.
- New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA.
- IFN-alpha inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release.
- A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered- dose inhalers.
- Metered dose inhaler: past, present, and future.
- The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma.
- Budesonide in grass pollen rhinitis.
- Immunotherapy with allergens.
- The nasal response to histamine challenge: effect of the pollen season and immunotherapy.
- Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells.
- Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity.
- Frequency of booster injections of allergoids.
- Mediator release after allergic and physical nasal challenges.
- Role of human basophils and mast cells in the pathogenesis of allergic diseases.
- Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
- Immunotherapy in asthma.
- Responses to ragweed-pollen nasal challenge before and after immunotherapy.
- Mediator release after nasal airway challenge with allergen.
- Why standardized extracts are necessary.
- Mediator release during nasal provocation. A model to investigate the pathophysiology of rhinitis.
- Peptide leukotriene release after antigen challenge in patients sensitive to ragweed.
- IgE-mediated leukotriene release in vitro and in vivo.
- Dose response of IgE and IgG antibodies during ragweed immunotherapy.
- Characteristics of human IgE antibody responses in vivo.
- An unusual case of asthma with onset late in life.
- Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
- Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults.
- T mycoplasma in human reproductive failure.
- Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study Group.
- The use of twice daily nedocromil sodium in the treatment of asthma.
- Advances in synthetic peptide immuno-regulatory epitopes.
- The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children.
- Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
- Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
- Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respirato...
- Comparison of an inhaled corticosteroid (triamcinolone acetonide) to a long-acting bronchodilator (salmeterol), the combination, and placebo in mild-moderate adult ast...
- The consideration of immunotherapy in the treatment of allergic asthma.
- Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity.
- Managing asthma in adults.
- Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human pat...
- Sublingual immunotherapy for cat allergy.
- Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies.
- Ragweed immunotherapy in adult asthma.
- Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis.
- The role of immunotherapy in allergic rhinitis/allergic asthma.
- Effects of nedocromil sodium on inflammation and symptoms in therapeutic studies.
- Treatment of cat allergy with T-cell reactive peptides.
- Clinical and immunologic effects of component peptides in Allervax Cat.
- A double-blind study of the discontinuation of ragweed immunotherapy.
Schools
Medical University of South Carolina
Johns Hopkins Hospital
Med University Sc Med Center
Doctors Specialties
- Allergy
- Internal Medicine
- Immunology
Accepted Insurances
Awards
- Fellow (FAAAAI)
- Super Doctor
- Top MD
Education
-
Johns Hopkins University -
Medical University of South Carolina -
Medical University of South Carolina College of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Demetrios J. Kalliongis, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. John P. Serlemitsos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chimene L. Liburd, MD
This Doctor is OpenDoctor Recommended.
|